# Evaluation of the Quality of Life of Patients With Metastatic Non-small Cell Lung Cancer With Supplementary Therapy With IGEN-0206

> **NCT04009122** · NA · COMPLETED · sponsor: **Igen BioLab SLU** · enrollment: 266 (actual)

## Conditions studied

- Quality of Life of Patients
- Non-small Cell Lung Cancer Metastatic

## Interventions

- **DIETARY_SUPPLEMENT:** IGEN0206
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04009122
- **Lead sponsor:** Igen BioLab SLU
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-11
- **Primary completion:** 2022-12-14
- **Final completion:** 2022-12-14
- **Target enrollment:** 266 (ACTUAL)
- **Last updated:** 2023-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04009122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04009122, "Evaluation of the Quality of Life of Patients With Metastatic Non-small Cell Lung Cancer With Supplementary Therapy With IGEN-0206". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04009122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*